Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00881322 · ClinicalTrials.gov registry record · NA
A Study on Intestinal Gas Symptoms to Evaluate the Effects of Gas Defense in Otherwise Healthy Adult
A NA study, sponsored by Miami Research Associates.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT00881322: Completed NA study, sponsored by Miami Research Associates.
NCT00881322 is a NA study that has completed, run by Miami Research Associates. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00881322, a NA study, has completed, sponsored by Miami Research Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled trial to determine the safety and efficacy of Digestive Advantage™ Gas Defense formula, a probiotic dietary supplement. The study will last approximately four weeks, and subjects will be seen at a screening/randomization visit, and two follow-up visits. Study procedures will include administering questionnaires for assessment of the study product's effect on intestinal gas symptoms and quality of life.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT BC-130 (Gas Defense)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00881322
The ClinicalTrials.gov registry entry for NCT00881322 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Miami Research Associates, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00881322 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00881322 about?
NCT00881322 is a clinical study titled "A Study on Intestinal Gas Symptoms to Evaluate the Effects of Gas Defense in Otherwise Healthy Adult". This is a randomized, double-blind, placebo-controlled trial to determine the safety and efficacy of Digestive Advantage™ Gas Defense formula, a probiotic dietary supplement. The study will last approximately four weeks, and subjects will be seen at a screening/randomization visit, and two follow-up...
What is the current status of trial NCT00881322?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2008-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00881322?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), BC-130 (Gas Defense) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00881322?
This trial is sponsored by Miami Research Associates, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.